Boston, MA, United States of America

Carlos Sanchez

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Cambridge, MA (US) (2024)
  • Boston, MA (US) (2024)

Company Filing History:


Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Carlos Sanchez

Introduction

Carlos Sanchez is a prominent inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the development of gene-modifying systems. With a total of 5 patents, his work focuses on innovative solutions for genetic disorders.

Latest Patents

Sanchez's latest patents include groundbreaking inventions such as CFTR-modulating compositions and methods. These disclosures provide compositions, systems, and methods for targeting, editing, modifying, or manipulating a host cell's genome at specific locations in a DNA sequence. His work specifically addresses gene-modifying systems for treating cystic fibrosis, particularly in subjects with the F508del mutation. Additionally, he has developed methods and compositions for modulating a genome, further advancing the capabilities of genetic engineering.

Career Highlights

Carlos Sanchez is currently associated with Flagship Pioneering Innovations Vi, LLC, where he continues to push the boundaries of genetic research. His innovative approach has garnered attention in the scientific community, and his patents reflect his commitment to improving health outcomes through technology.

Collaborations

Sanchez collaborates with notable professionals in his field, including Robert Charles Altshuler and Anne Helen Bothmer. These partnerships enhance the scope and impact of his research, fostering a collaborative environment for innovation.

Conclusion

Carlos Sanchez exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work not only contributes to scientific knowledge but also holds the potential to transform treatment options for genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…